Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice
AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E col...
Saved in:
Published in | Acta pharmacologica Sinica Vol. 25; no. 6; pp. 783 - 788 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.06.2004
|
Subjects | |
Online Access | Get full text |
ISSN | 1671-4083 1745-7254 |
Cover
Abstract | AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells,and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE, The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure,and DNA fragmentation assay. RESULTS: The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC50 was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GaIN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GaIN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. CONCLUSION: Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. |
---|---|
AbstractList | To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.AIMTo study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay.METHODSA cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay.The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice.RESULTSThe expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice.Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice.CONCLUSIONRecombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells, and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE. The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure, and DNA fragmentation assay. The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC(50) was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GalN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GalN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA fragment coding for Ile1363-Tyr1725 of human FN was inserted into the PinPoint Xa-3 plasmid, and the constructed plasmid was transformed into E coli BL21 (DE3) cells,and then the expression of rhFN polypeptide in DE3 cells was identified through SDS-PAGE, The target protein from the supernatant of bacteria lysate was purified through biotin-affinity chromatography. The bioactivity of the purified rhFN polypeptide was determined with cell adhesive activity. The survival rate was observed in endotoxemia mice injected with rhFN polypeptide. The tissue damage in hepatocyte was detected using histology, ultrastructure,and DNA fragmentation assay. RESULTS: The expression of rhFN polypeptide reached approximately 20 % of the total cellular protein. The adhesion ability of rhFN polypeptide was concentration-dependent. The value of EC50 was 0.8 nmol/L. The survival rate of endotoxemia mice sensitized by D-galactosamine (D-GaIN) was 60 % in rhFN polypeptide treated group, while that of endotoxemia mice sensitized by D-GaIN was 20 % in the control group (P<0.01). Histopathology showed that less necrosis occurred on the hepatocyte of endotoxemia mice injected with rhFN polypeptide compared with saline control. Ultrastructure and DNA fragmentation assay showed that no apoptotic hepatocyte was observed in the liver of rhFN-treated endotoxemia mice. CONCLUSION: Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. |
Author | YongWU Yuan-zhongCHEN Hui-fangHUANG PingCHEN |
AuthorAffiliation | FujianInstituteofHematology,UnionHospital,FujianMedicalUniversity,Fuzhou350001,China |
Author_xml | – sequence: 1 givenname: Yong surname: Wu fullname: Wu, Yong organization: Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou 350001, China – sequence: 2 givenname: Yuan-Zhong surname: Chen fullname: Chen, Yuan-Zhong – sequence: 3 givenname: Hui-Fang surname: Huang fullname: Huang, Hui-Fang – sequence: 4 givenname: Ping surname: Chen fullname: Chen, Ping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15169632$$D View this record in MEDLINE/PubMed |
BookMark | eNo1kNtKxDAQhoOsuAd9BYk33hVyarO5lMUTLAiid0LJYbIbbZPatOD69BZ2hYF_4P_mu5glmsUU4QwtqBRlIVkpZtNeSVoIsuZztMz5kxDOOFUXaE5LWqmKswX6eAWbWhOijgP2wfSTxQ4h4i41hw66ITjAU6d3KYZfyHgPnR6CxV6HZuwBh-hGCw6bA4bo0pB-puNp2mDhEp173WS4OuUKvT_cv22eiu3L4_PmbltYxvlQCO21NIIwCVoKINJrYggjtCLMUu6dkaZcl8yJ0lagqNDOEquUJwwqJhhfodujt-vT9wh5qNuQLTSNjpDGXEuqJCmVmsDrEziaFlzd9aHV_aH-_8cE3BwBu09x9x3irjbafvnQQK3UmjBW8T-FrGuA |
ContentType | Journal Article |
DBID | 2RA 92L CQIGP W91 ~WA CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1745-7254 |
EndPage | 788 |
ExternalDocumentID | 15169632 9980226 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -05 -0E -Q- -SE -S~ .3N 0R~ 188 1OC 23M 2RA 2WC 31~ 36B 3V. 4.4 53G 5GY 5VR 5VS 6J9 70F 7X7 8-1 88E 8FI 8FJ 8R4 8R5 8RM 92L 92M 9D9 9DE A8Z AADWK AANZL AAPBV AAWBL AAYJO AAZLF ABAWZ ABDEU ABKZE ABUWG ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIWK ACKTT ACPRK ACRQY ACTTH ACVWB ACXQS ADBBV ADFRT ADHDB ADMDM ADQMX ADRAZ ADYYL AEDAW AEFTE AEJRE AENEX AEXYK AFBPY AFKRA AFRAH AFSHS AFUIB AFZJQ AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AINHJ AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS AXYYD BAWUL BBAFP BBNVY BENPR BFHJK BHPHI BKKNO BPHCQ BVXVI C1A CAG CAJEE CAJUS CCEZO CDYEO CHBEP CIEJG CO8 COF CQIGP CS3 CW9 CXBCV DIK DNIVK E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FA0 FDQFY FERAY FIZPM FSGXE FYUFA GX1 HCIFZ HH5 HYE HZI HZ~ JSO JUIAU JZLTJ K97 KQ8 LH4 LW6 M1P M48 M7P MK0 NQJWS NYICJ O9- OK1 OVD P2P P6G PQEST PQQKQ PQUKI PROAC PSQYO Q-- Q-4 Q2X R-E RNT RNTTT RPM RT5 S.. SNX SNYQT SRMVM SV3 SWTZT T8U TAOOD TBHMF TDRGL TEORI TR2 TSG U1F U1G U5E U5O UKHRP UMP UZ5 W91 ~88 ~NG ~WA 406 AACDK AASML AATNV AAXDM ABAKF ABZZP ACAOD ACMJI ACZOJ AEFQL AEMSY AESKC AEVLU AFBBN AGQEE AIGIU AJAOE ALIPV CCPQU CGR CUY CVF DPUIP ECM EIF FIGPU HMCUK IWAJR LGEZI LOTEE NADUK NPM NXXTH ROL SOHCF 7X8 SOJ |
ID | FETCH-LOGICAL-c233t-4afa7b4027ea74e07fa0b0201602c13fdb7b5852d45c6e914adc0c99f02e62423 |
ISSN | 1671-4083 |
IngestDate | Fri Sep 05 13:05:54 EDT 2025 Wed Feb 19 01:40:51 EST 2025 Thu Nov 24 20:31:58 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c233t-4afa7b4027ea74e07fa0b0201602c13fdb7b5852d45c6e914adc0c99f02e62423 |
Notes | R575 31-1347/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15169632 |
PQID | 71970599 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_71970599 pubmed_primary_15169632 chongqing_backfile_9980226 |
PublicationCentury | 2000 |
PublicationDate | 2004-06-01 |
PublicationDateYYYYMMDD | 2004-06-01 |
PublicationDate_xml | – month: 06 year: 2004 text: 2004-06-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Acta pharmacologica Sinica |
PublicationTitleAlternate | Acta Pharmacologica Sinica |
PublicationYear | 2004 |
SSID | ssj0032319 |
Score | 1.7190052 |
Snippet | AIM: To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. METHODS: A cDNA... To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice. A cDNA fragment coding for... To study the preventive effect of recombinant human fibronectin (rhFN) polypeptide on hepatic failure induced by endotoxin in mice.AIMTo study the preventive... |
SourceID | proquest pubmed chongqing |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 783 |
SubjectTerms | Animals Apoptosis - drug effects Cell Adhesion Cells, Cultured Cricetinae Endotoxemia - chemically induced Endotoxemia - pathology Fibronectins - pharmacology Galactosamine Humans Kidney - cytology Lipopolysaccharides Liver - pathology Liver Failure - chemically induced Liver Failure - pathology Male Mice Mice, Inbred BALB C Peptide Fragments - pharmacology Recombinant Proteins - pharmacology 乙酰半乳糖胺 内毒素 抵抗作用 肝坏死 诱导作用 重组纤维结合蛋白多肽 |
Title | Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice |
URI | http://lib.cqvip.com/qk/95561A/20046/9980226.html https://www.ncbi.nlm.nih.gov/pubmed/15169632 https://www.proquest.com/docview/71970599 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZrn_Yydl-6rtXD6EvqYVuKFT-O0RBG1wXmQDYGRpIlGkadrLFh6a_fObJie7RjlxdjFDuxz6d8Pp91LoS8NlIUkhWAgEySgBszDsaJDAONvboF7EmD-c4fLpLpnL9fjBZdtzeXXVKpN_rmzryS_0EVxgBXzJL9B2TbL4UB2Ad8YQsIw_avMEbteKVcLMvQgu5dlUhfJXZeAHkJZFDg4gCuO5XLG7MBr3DtCrRaucRo9CHo8Vo3LqgpQZ6ufixd4OOVD4hry9PqSg7XXZFrAHb4yWVUtpxeOy5f-eegixdoCO1zLcvgy2Xvk2nt31FP62UwkbdPme0ep7u3EbyLmvIEmgjUpE1zmh3DNqnNfib16VL4434pg33xMZ_Mz8_z7GyR7ZE9Frkc7kUbucPAJUVV0_4UlsXA2_gOV_d7oeAchuwheeA9ffq2ge0RuWfKx-Rk1lhxe0qzLvNtc0pP6Kyz7_YJ-drDlvawpT1saQ9b6rGlHlvqsaVqS1tsYZAitk_JfHKWvZsGvhNGoGPGqoBLK4UCqS_gv8VNKKwMFTj6URLGOmK2UEKB7osLPtKJSSMuCx3qNLVhbDABiD0j-yVc5wtCjRpLOyrGBpQyZ0ynIyZTywspY8tTzQfkoDUmeFL6G9YHy0GUg7OXDMjxzro50BCuLcnSrOpNLqJUYKmfAXneGD1fN9VS8ghXYhMWH_zx3JfkfjelDsl-dV2bV-DyVerITYCf7DZimg |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recombinant+fibronectin+polypeptide+antagonizes+hepatic+failure+induced+by+endotoxin+in+mice&rft.jtitle=Acta+pharmacologica+Sinica&rft.au=Wu%2C+Yong&rft.au=Chen%2C+Yuan-Zhong&rft.au=Huang%2C+Hui-Fang&rft.au=Chen%2C+Ping&rft.date=2004-06-01&rft.issn=1671-4083&rft.volume=25&rft.issue=6&rft.spage=783&rft.externalDBID=NO_FULL_TEXT |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F95561A%2F95561A.jpg |